Senior Manager, Global Procurement Japan at Bristol-Myers Squibb

Kariya-shi, Aichi, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, BiotechnologyIndustries

Requirements

Experience in global procurement or supply chain management, with a focus on Japan market
Senior-level management expertise in procurement operations
Ability to work onsite as per BMS occupancy structure (site-essential or site-by-design with at least 50% onsite presence)
Capability for physical travel to visit customers, patients, or business partners if field-based
Full Covid-19 vaccination and up-to-date boosters strongly recommended
Qualifications suitable for employment considering arrest and conviction records per applicable laws

Responsibilities

Lead global procurement strategies and operations specific to Japan
Collaborate with high-achieving teams to optimize procurement processes
Drive innovation and accountability in procurement activities
Ensure compliance with onsite work protocols and essential job functions requiring physical presence
Contribute to transforming patients' lives through effective procurement supporting science and production
Promote company values of passion, innovation, urgency, accountability, inclusion, and integrity in procurement role

Skills

Procurement

Strategic Sourcing

Supplier Management

Contract Negotiation

Supply Chain Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free